We are interested in mechanisms of tumor initiation and resistance, with an emphasis on tissue long lived cells such as stromal cells, and their crosstalk with tumor cells, immune cells and the vasculature. We perform mostly in vivo studies combining
We are investigating bacteria/bacteriophages interactions, and the genetic innovation that happens at this interface. This includes work on fascinating genetic systems such as CRISPR-Cas, other novel anti-phage systems, and Diversity Generating